{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:47:54Z","timestamp":1788634074375,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.biopha.2018.01.058","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T11:53:18Z","timestamp":1519127598000},"page":"499-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The Protective effect of P7C3 against DNA and neuron damage in rat pups with congenital hypothyroidism"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-0760","authenticated-orcid":false,"given":"Halef Okan","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Eray","family":"Alcigir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"115","key":"10.1016\/j.biopha.2018.01.058_bib0005","first-page":"12","article-title":"Cognitive profiles of patients with early detected and treated congenital hypothyroidism","volume":"1","author":"Pardo","year":"2017","journal-title":"Arch. Argent. Pediatr."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.annepidem.2015.11.005","article-title":"Increased incidence of congenital hypothyroidism in France from 1982 to 2012: a nationwide multicenter analysis","volume":"26","author":"Barry","year":"2016","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.058_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1172-5-17","article-title":"Congenital hypothyroidism","volume":"5","author":"Rastogi","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1542\/neo.9-2-e66","article-title":"Hypothyroxinemia and prematurity","volume":"9","author":"Forghani","year":"2008","journal-title":"Neoreviews"},{"issue":"4","key":"10.1016\/j.biopha.2018.01.058_bib0025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuro.2011.11.005","article-title":"Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences","volume":"33","author":"Gilbert","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2018.01.058_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.09.070","article-title":"Influence of maternal thyroid hormones during gestation on fetal brain development","volume":"342","author":"Moog","year":"2017","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/tox.22034","article-title":"8-hydroxy-2\u2032-deoxyguanosine as a biomarker of oxidative DNA damage induced by perfluorinated compounds in TK6 cells","volume":"31","author":"Yahia","year":"2016","journal-title":"Environ. Toxicol."},{"issue":"27","key":"10.1016\/j.biopha.2018.01.058_bib0040","article-title":"8-hydroxy-2\u2032 -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"7","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health Part C"},{"issue":"12","key":"10.1016\/j.biopha.2018.01.058_bib0045","doi-asserted-by":"crossref","first-page":"e0168894","DOI":"10.1371\/journal.pone.0168894","article-title":"Single versus serial measurements of neuron-specific enolase and prediction of poor neurological outcome in persistently unconscious patients after out-Of-Hospital cardiac arrest \u2013 a TTM-trial substudy","volume":"18","author":"Wiberg","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.058_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/exnr.1999.7147","article-title":"Expression of neuron-specific enolase in adult rat brain following status epilepticus","volume":"159","author":"Schreiber","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2018.01.058_bib0055","first-page":"371","article-title":"Time profile of neuron specific enolase serum levels after experimental brain injury in rat","volume":"76","author":"Woertgen","year":"2000","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.biopha.2018.01.058_bib0060","first-page":"93","article-title":"Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer\u2019s disease?","volume":"23","author":"Palumbo","year":"2008","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.biopha.2018.01.058_bib0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0304-3940(98)00992-6","article-title":"Increase of neuron-specific enolase in patients with Creutzfeldt-Jakob disease","volume":"12","author":"Kropp","year":"1999","journal-title":"Neurosci. Lett. Feb."},{"key":"10.1016\/j.biopha.2018.01.058_bib0070","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2337\/dc13-0590","article-title":"NSE, a potential biomarker, is closely connected to diabetic peripheral neuropathy","volume":"36","author":"Li","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2018.01.058_bib0075","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.289.6459.1645","article-title":"Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for \"tissue thyrotoxicosis","volume":"289","author":"Jennings","year":"1984","journal-title":"Br. Med. J."},{"issue":"331","key":"10.1016\/j.biopha.2018.01.058_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1056\/NEJM199407213310307","article-title":"Thyroxine therapy","volume":"21","author":"Wood","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.biopha.2018.01.058_bib0085","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1039\/C3CS60448A","article-title":"P7C3 and an unbiased approach to drug discovery for neurodegenerative diseases","volume":"43","author":"Pieper","year":"2014","journal-title":"Chem. Soc."},{"key":"10.1016\/j.biopha.2018.01.058_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.06.018","article-title":"Discovery of a proneurogenic, neuroprotective chemical","volume":"9","author":"Pieper","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.01.058_bib0095","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.07.040","article-title":"P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2018.01.058_bib0100","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease","volume":"16","author":"De Jes\u00fas-Cort\u00e9s","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.01.058_bib0105","doi-asserted-by":"crossref","first-page":"15010","DOI":"10.1038\/npjparkd.2015.10","article-title":"Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"1","author":"De Jes\u00fas-Cort\u00e9s","year":"2015","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.biopha.2018.01.058_bib0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/neu.2013.3135","article-title":"Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury","volume":"1","author":"Blaya","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2018.01.058_bib0115","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.celrep.2014.08.030","article-title":"P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury","volume":"25","author":"Yin","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2018.01.058_bib0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2017.01.006","article-title":"The neuroprotective compound P7C3-A20 promotes neurogenesis and improves cognitive function after ischemic stroke","volume":"290","author":"Loris","year":"2017","journal-title":"Exp. Neurol."},{"issue":"17","key":"10.1016\/j.biopha.2018.01.058_bib0125","article-title":"(-)-P7C3-S243 protects a rat model of Alzheimer\u2019s disease from neuropsychiatric deficits and neurodegeneration without altering amyloid deposition or reactive glia","volume":"3223","author":"Voorhees","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2018.01.058_bib0130","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.1213960109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis","volume":"16","author":"Tesla","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.01.058_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2014.10.005","article-title":"Pharmacologic rescue of motor and sensory function by the neuroprotective compound P7C3 following neonatal nerve injury","volume":"22","author":"Kemp","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.01.058_bib0140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/mp.2014.34","article-title":"The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis","volume":"20","author":"Walker","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"38","key":"10.1016\/j.biopha.2018.01.058_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12020-010-9376-7","article-title":"Oxidative DNA damage: the thyroid hormone-mediated effects of insulin on liver tissue","volume":"12","author":"Altan","year":"2010","journal-title":"Endocrine"},{"issue":"28","key":"10.1016\/j.biopha.2018.01.058_bib0150","first-page":"761","article-title":"Evaluation of inflammatory and oxidative biomarkers in children with well-controlled congenital hypothyroidism","volume":"1","author":"Qiu","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2018.01.058_bib0155","first-page":"603","article-title":"Hypothyroidism and the aorta. evidence of increased oxidative DNA damage to the aorta of hypothyroid rats","volume":"22","author":"Moulakakis","year":"2008","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.biopha.2018.01.058_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1556\/APhysiol.92.2005.1.6","article-title":"The effect of thyroxine administration on lipid peroxidation in different tissues of rats with hypothyroidism","volume":"92","author":"Mogulkoc","year":"2005","journal-title":"Acta Physiol. Hung."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.058_bib0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cbf.1616","article-title":"Increased resistance to hydrogen peroxide-induced cardiac contracture is associated with decreased myocardial oxidative stress in hypothyroid rats","volume":"28","author":"da Rosa Araujo","year":"2010","journal-title":"Cell Biochem. Funct."},{"issue":"43","key":"10.1016\/j.biopha.2018.01.058_bib0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12020-012-9801-1","article-title":"Levothyroxine replacement therapy with vitamin E supplementation prevents oxidative stress and cognitive deficit in experimental hypothyroidism","volume":"23","author":"Pan","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.biopha.2018.01.058_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6757154","article-title":"Thyroid hormones, oxidative stress, and inflammation","volume":"2016","author":"Mancini","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.biopha.2018.01.058_bib0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11011-008-9099-0","article-title":"Hypothyroidism induces selective oxidative stress in amygdala and hippocampus of rat","volume":"23","author":"Cano-Europa","year":"2008","journal-title":"Metab. Brain. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2018.01.058_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042357","article-title":"Age-associated changes in oxidative stress and NAD++ metabolism in human tissue","volume":"27","author":"Massudi","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2018.01.058_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1439-0272.2003.00548.x","article-title":"Experimentally induced hypo- and hyper-thyroidism influence on the antioxidant defence system in adult rat testis","volume":"35","author":"Choudhury","year":"2003","journal-title":"Andrologia"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00008506-199304000-00007","article-title":"Neuron-specific enolase as a marker of in vitro neuronal damage. Part I: assessment of neuron-specific enolase as a quantitative and specific marker of neuronal damage","volume":"5","author":"Hans","year":"1993","journal-title":"J. Neurosurg. Anesthesiol."},{"issue":"4","key":"10.1016\/j.biopha.2018.01.058_bib0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1227\/NEU.0000000000001140","article-title":"The relationship between serum neuron-specific enolase levels and severity of bleeding and functional outcomes in patients with nontraumatic subarachnoid hemorrhage","volume":"78","author":"Tawk","year":"2016","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-1211(97)00040-5","article-title":"Serum neuron-specific enolase is a marker for neuronal damage following status epilepticus in the rat","volume":"28","author":"Sankar","year":"1997","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.01.058_bib0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/01616412.2016.1144410","article-title":"S100B and neuron-specific enolase as mortality predictors in patients with severe traumatic brain injury","volume":"38","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2016","journal-title":"Neurol. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.01.058_bib0215","doi-asserted-by":"crossref","first-page":"e0152268","DOI":"10.1371\/journal.pone.0152268","article-title":"Neuron-specific enolase is correlated to compromised cerebral metabolism in patients suffering from acute bacterial meningitis; an observational cohort study","volume":"28","author":"Bartek","year":"2016","journal-title":"PLoS One"},{"issue":"165","key":"10.1016\/j.biopha.2018.01.058_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1650001","article-title":"Thyroid hormone and central nervous system development","volume":"1","author":"Chan","year":"2000","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2018.01.058_bib0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.devbrainres.2004.10.005","article-title":"Congenital hypothyroidism alters the phosphorylation of ERK1\/2 and p38MAPK in the hippocampus of neonatal rats","volume":"154","author":"Calloni","year":"2005","journal-title":"Dev. Brain Res."},{"issue":"375","key":"10.1016\/j.biopha.2018.01.058_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2013.05.001","article-title":"Congenital hypothyroidism alters the oxidative status, enzyme activities and morphological parameters in the hippocampus of developing rats","volume":"15","author":"Cattani","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"591","key":"10.1016\/j.biopha.2018.01.058_bib0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neulet.2015.02.008","article-title":"Chronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of down syndrome [corrected]","volume":"30","author":"Latchney","year":"2015","journal-title":"Neurosci. Lett."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217349375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:23:06Z","timestamp":1781590986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217349375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":47,"alternative-id":["S0753332217349375"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.058","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Protective effect of P7C3 against DNA and neuron damage in rat pups with congenital hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}